Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)

Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers in non-small-cell lung cancer (NSCLC). Significant developments have taken place which highlight the differences in tumor biology that exist between the mutant and wild-type subtypes of NSCLC. Patients with advan...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Leary, Connor, Gasper, Harry, Sahin, Katherine B., Tang, Ming, Kulasinghe, Arutha, Adams, Mark N., Richard, Derek J., O’Byrne, Ken J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600164/
https://www.ncbi.nlm.nih.gov/pubmed/32992872
http://dx.doi.org/10.3390/ph13100273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600164/
https://www.ncbi.nlm.nih.gov/pubmed/32992872
http://dx.doi.org/10.3390/ph13100273

Ejemplares similares